Global Implantable Ports Industry

Global Implantable Ports Industry

  • April 2021 •
  • 125 pages •
  • Report ID: 5957030 •
  • Format: PDF
Abstract:
- Global Implantable Ports Market to Reach $238.9 Million by 2027
- Amid the COVID-19 crisis, the global market for Implantable Ports estimated at US$196.2 Million in the year 2020, is projected to reach a revised size of US$238.9 Million by 2027, growing at aCAGR of 2.9% over the period 2020-2027. Single-Lumen, one of the segments analyzed in the report, is projected to record 3% CAGR and reach US$138.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Double-Lumen segment is readjusted to a revised 2.6% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $57.7 Million, While China is Forecast to Grow at 2.7% CAGR
- The Implantable Ports market in the U.S. is estimated at US$57.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$42.6 Million by the year 2027 trailing a CAGR of 2.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.7% and 2.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

- Select Competitors (Total 41 Featured) -
  • AngioDynamics, Inc.
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Cook Medical, Inc.
  • Districlass Medical SA
  • Kimal PLC
  • Medical Components, Inc.
  • Pakumed Medical Products Gmbh
  • PFM Medical AG
  • Smiths Medical
  • Teleflex, Inc.
  • Vygon SA